arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

DNA X, Inc.

SONM
$3.78 ▲ +0.04 (+1.07%) at close
Industrials ·Telephone & Telegraph Apparatus ·USTelephone & Telegraph Apparatus
34 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
83
Health
Excellent
Bullish
auto_awesome

Analytical Summary

DNA X, Inc. shows strong fundamentals with top-quartile Return on Common Equity (%) and Debt to Equity. The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $4.8M
Dividend Yield
Revenue Growth None
Op. Margin None
ROIC -6691.8%
FCF / Share $-2.74
Trailing P/E 0.8x
Price / Book
FCF Yield
Debt / Equity -1.09
info Valuation on last close. End-of-day price, Aug 7, 2026.

34-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$16.21M
↑ +7.9%
Net Income Profit after all expenses
$6.34M
↑ +1284.3%
Operating Margin Operating profit as % of sales
-24.5%
↑ +59.2%
FCF / Share Free cash flow per share
$-2.74
↓ -66.6%
Long-Term Debt Long-term obligations
$1.07M
↓ -78.8%
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Returns
100
Financial Health
68
Cash Quality
71

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 9 years · 34 quarters